Dudediligence.

Abbott Laboratories

ABTNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$10.63BSep ’24$10.97BDec ’24$10.36BMar ’25$11.14BJun ’25$11.37BSep ’25$11.46BDec ’25$11.16BMar ’26$12.59BJun ’26
Net income, by quarter
$1.65BSep ’24$9.23BDec ’24$1.32BMar ’25$1.78BJun ’25$1.64BSep ’25$1.78BDec ’25$1.08BMar ’26$928.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$43.08B$43.65B$40.11B$41.95B$44.33B
Gross profit$24.54B$24.51B$22.13B$23.24B$25.01B
Operating income$8.43B$8.36B$6.48B$6.83B$8.05B
Net income$7.07B$6.93B$5.72B$13.40B$6.52B
Operating cash flow$10.53B$9.58B$7.26B$8.56B$9.57B
Free cash flow$8.65B$7.80B$5.06B$6.35B$7.39B
Cash$9.80B$9.88B$6.90B$7.62B$8.52B
Debt$18.05B$16.77B$14.68B$14.13B$12.93B
Shares outstanding1.99B1.99B1.99B1.99B2.00B